Massive Bio Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 20
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $400K
Latest Deal Amount
  • Investors
  • 12

Massive Bio General Information

Description

Developer of an AI-driven platform intended to connect cancer patients to biopharmaceutical clinical trials. The company's platform generates a precise oncology plan which helps users to incorporate tumor profiling, targeted therapies, and outcome tracking into their daily decisions, thereby enabling patients to get an effective treatment without disrupting lives and becoming a financial hindrance.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Media and Information Services (B2B)
Information Services (B2C)
Other Healthcare Services
Primary Office
  • 90 West Street
  • Suite 12M
  • New York, NY 10006
  • United States
+1 (917) 000-0000

Massive Bio Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Massive Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 17-Dec-2020 $400K 00.000 Completed Generating Revenue
3. Later Stage VC 30-Oct-2020 00.00 00.000 Completed Generating Revenue
2. Later Stage VC (Series A) 10-Apr-2019 $2.53M $4.03M 000.00 Completed Generating Revenue
1. Angel (individual) 16-Dec-2015 $1.5M $1.5M Completed Startup
To view Massive Bio’s complete valuation and funding history, request access »

Massive Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 000,000 00.000000 00.00 000.00 000.00 00 000.00 0.000
To view Massive Bio’s complete cap table history, request access »

Massive Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of an AI-driven platform intended to connect cancer patients to biopharmaceutical clinical trials. The company
Other Healthcare Technology Systems
New York, NY
20 As of 2021
00.000
0000000000 00.000

00000000

consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nu
00000 0000000000 0000000000 0000000
Stamford, CT
00 As of 0000
00.00
000 0000-00-00
00000000000 00.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Massive Bio Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
000000000000 Venture Capital-Backed Stamford, CT 00 00.00 00000000000 00.00
You’re viewing 1 of 1 competitors. Get the full list »

Massive Bio Executive Team (8)

Name Title Board Seat Contact Info
Selin Kurnaz Ph.D Co-Founder & Chief Executive Officer
Cagatay Culcuoglu Co-Founder, Chief Operating Officer & Chief Technology Officer
Aymen Elfiky Co-Founder & CMIO
Kristin Johnston Chief Nursing Officer
Arturo Loaiza-Bonilla MD Co-Founder, Board Member & Chief Medical Advisor
You’re viewing 5 of 8 executive team members. Get the full list »

Massive Bio Board Members (6)

Name Representing Role Since
Gyan Kapur Self Board Member and Commercial Advisor 000 0000
Kojo Appenteng Massive Bio Board Member and Commercial Advisor 000 0000
Paul Tanico JD Self Board Member and Commercial Advisor 000 0000
Primo Beadling Massive Bio Board Member and Commercial Advisor 000 0000
Rina Sirinoglu Massive Bio Board Member and Commercial Advisor 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Massive Bio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Massive Bio Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Cancer Institute Government Minority 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Catalytic Impact Foundation Not-For-Profit Venture Capital Minority 000 0000 000000 0
Cavendish Impact Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »